Conditional Deletion of Smad1 and Smad5 in Somatic Cells of Male and Female Gonads Leads to Metastatic Tumor Development in Mice

REFERENCES

• Arnold, S. J., S. Maretto, A. Islam, E. K. Bikoff, and E. J. Robertson. 2006. Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo. Dev. Biol. 296:104–118.
   PubMed Web of Science ®Google Scholar
• Beck, S. E., B. H. Jung, A. Fiorino, J. Gomez, E. D. Rosario, B. L. Cabrera, S. C. Huang, J. Y. Chow, and J. M. Carethers. 2006. Bone morphogenetic protein signaling and growth suppression in colon cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 291:G135–G145.
   PubMed Web of Science ®Google Scholar
• Bevan, S., K. Woodford-Richens, P. Rozen, C. Eng, J. Young, M. Dunlop, K. Neale, R. Phillips, D. Markie, M. Rodriguez-Bigas, B. Leggett, E. Sheridan, S. Hodgson, T. Iwama, D. Eccles, W. Bodmer, R. Houlston, and I. Tomlinson. 1999. Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome. Gut 45:406–408.
   PubMedGoogle Scholar
• Boerboom, D., M. Paquet, M. Hsieh, J. Liu, S. P. Jamin, R. R. Behringer, J. Sirois, M. M. Taketo, and J. S. Richards. 2005. Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development. Cancer Res. 65:9206–9215.
   PubMed Web of Science ®Google Scholar
• Brubaker, K. D., E. Corey, L. G. Brown, and R. L. Vessella. 2004. Bone morphogenetic protein signaling in prostate cancer cell lines. J. Cell. Biochem. 91:151–160.
   PubMed Web of Science ®Google Scholar
• Buckhaults, P., C. Rago, B. St. Croix, K. E. Romans, S. Saha, L. Zhang, B. Vogelstein, and K. W. Kinzler. 2001. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res. 61:6996–7001.
   PubMed Web of Science ®Google Scholar
• Chang, H., C. W. Brown, and M. M. Matzuk. 2002. Genetic analysis of the mammalian TGF-β superfamily. Endocr. Rev. 23:787–823.
   PubMed Web of Science ®Google Scholar
• Chang, H., D. Huylebroeck, K. Verschueren, Q. Guo, M. M. Matzuk, and A. Zwijsen. 1999. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 126:1631–1642.
   PubMed Web of Science ®Google Scholar
• Cheng, K. H., J. F. Ponte, and S. Thiagalingam. 2004. Elucidation of epigenetic inactivation of SMAD8 in cancer using targeted expressed gene display. Cancer Res. 64:1639–1646.
   PubMedGoogle Scholar
• Coerver, K. A., T. K. Woodruff, M. J. Finegold, J. Mather, A. Bradley, and M. M. Matzuk. 1996. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Mol. Endocrinol. 10:534–543.
   PubMed Web of Science ®Google Scholar
• David, L., C. Mallet, S. Mazerbourg, J. J. Feige, and S. Bailly. 2007. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase (ALK1) in endothelial cells. Blood 109:1953–1961.
   PubMed Web of Science ®Google Scholar
• Dennis, G., Jr., B. T. Sherman, D. A. Hosack, J. Yang, W. Gao, H. C. Lane, and R. A. Lempicki. 2003. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4:P3.
   PubMed Web of Science ®Google Scholar
• Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29:117–129.
   PubMed Web of Science ®Google Scholar
• Durlinger, A. L., P. Kramer, B. Karels, F. H. de Jong, J. T. Uilenbroek, J. A. Grootegoed, and A. P. Themmen. 1999. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140:5789–5796.
   PubMed Web of Science ®Google Scholar
• Feng, X. H., and R. Derynck. 2005. Specificity and versatility in tgf-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 21:659–693.
   PubMed Web of Science ®Google Scholar
• Gemma, A., K. Hagiwara, F. Vincent, Y. Ke, A. R. Hancock, M. Nagashima, W. P. Bennett, and C. C. Harris. 1998. hSmad5 gene, a human hSmad family member: its full length cDNA, genomic structure, promoter region and mutation analysis in human tumors. Oncogene 16:951–956.
   PubMedGoogle Scholar
• Goumans, M. J., G. Valdimarsdottir, S. Itoh, A. Rosendahl, P. Sideras, and P. ten Dijke. 2002. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 21:1743–1753.
   PubMed Web of Science ®Google Scholar
• He, X. C., J. Zhang, W. G. Tong, O. Tawfik, J. Ross, D. H. Scoville, Q. Tian, X. Zeng, X. He, L. M. Wiedemann, Y. Mishina, and L. Li. 2004. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet. 36:1117–1121.
   PubMed Web of Science ®Google Scholar
• Horvath, L. G., S. M. Henshall, J. G. Kench, J. J. Turner, D. Golovsky, P. C. Brenner, G. F. O'Neill, R. Kooner, P. D. Stricker, J. J. Grygiel, and R. L. Sutherland. 2004. Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Prostate 59:234–242.
   PubMed Web of Science ®Google Scholar
• Howe, J. R., J. L. Bair, M. G. Sayed, M. E. Anderson, F. A. Mitros, G. M. Petersen, V. E. Velculescu, G. Traverso, and B. Vogelstein. 2001. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 28:184–187.
   PubMed Web of Science ®Google Scholar
• Huang, S., B. Tang, D. Usoskin, R. J. Lechleider, S. P. Jamin, C. Li, M. A. Anzano, T. Ebendal, C. Deng, and A. B. Roberts. 2002. Conditional knockout of the Smad1 gene. Genesis 32:76–79.
   PubMedGoogle Scholar
• Jamin, S. P., N. A. Arango, Y. Mishina, M. C. Hanks, and R. R. Behringer. 2002. Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat. Genet. 7:7.
   Google Scholar
• Jarvinen, H., and K. O. Franssila. 1984. Familial juvenile polyposis coli; increased risk of colorectal cancer. Gut 25:792–800.
   PubMedGoogle Scholar
• Jeyasuria, P., Y. Ikeda, S. P. Jamin, L. Zhao, D. G. De Rooij, A. P. Themmen, R. R. Behringer, and K. L. Parker. 2004. Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol. Endocrinol. 18:1610–1619.
   PubMed Web of Science ®Google Scholar
• Jorgez, C. J., M. Klysik, S. P. Jamin, R. R. Behringer, and M. M. Matzuk. 2004. Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol. Endocrinol. 18:953–967.
   PubMed Web of Science ®Google Scholar
• Kowanetz, M., U. Valcourt, R. Bergstrom, C. H. Heldin, and A. Moustakas. 2004. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol. Cell. Biol. 24:4241–4254.
   PubMed Web of Science ®Google Scholar
• Li, Q., J. M. Graff, A. E. O'Connor, K. L. Loveland, and M. M. Matzuk. 2007. SMAD3 regulates gonadal tumorigenesis. Mol. Endocrinol. 21:2472–2486.
   PubMedGoogle Scholar
• Looyenga, B. D., and G. D. Hammer. 2007. Genetic removal of smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery. Mol. Endocrinol. 21:2440–2457.
   PubMedGoogle Scholar
• Massague, J., S. W. Blain, and R. S. Lo. 2000. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103:295–309.
   PubMed Web of Science ®Google Scholar
• Massague, J., J. Seoane, and D. Wotton. 2005. Smad transcription factors. Genes Dev. 19:2783–2810.
   PubMed Web of Science ®Google Scholar
• Matzuk, M., M. Finegold, J. Su, A. Hsueh, and A. Bradley. 1992. α-Inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 360:313–319.
   PubMed Web of Science ®Google Scholar
• Minn, A. J., G. P. Gupta, P. M. Siegel, P. D. Bos, W. Shu, D. D. Giri, A. Viale, A. B. Olshen, W. L. Gerald, and J. Massague. 2005. Genes that mediate breast cancer metastasis to lung. Nature 436:518–524.
   PubMed Web of Science ®Google Scholar
• Miyazaki, H., T. Watabe, T. Kitamura, and K. Miyazono. 2004. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells. Oncogene 23:9326–9335.
   PubMed Web of Science ®Google Scholar
• Miyazono, K., S. Maeda, and T. Imamura. 2005. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16:251–263.
   PubMed Web of Science ®Google Scholar
• Naora, H., and D. J. Montell. 2005. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat. Rev. Cancer 5:355–366.
   PubMed Web of Science ®Google Scholar
• Pangas, S. A., C. J. Jorgez, and M. M. Matzuk. 2004. Growth differentiation factor 9 regulates expression of the bone morphogenetic protein antagonist, gremlin. J. Biol. Chem. 279:32281–32286.
   PubMed Web of Science ®Google Scholar
• Pangas, S. A., C. J. Jorgez, M. Tran, J. Agno, X. Li, C. W. Brown, T. R. Kumar, and M. M. Matzuk. 2007. Intraovarian activins are required for female fertility. Mol. Endocrinol. 21:2458–2471.
   PubMedGoogle Scholar
• Pangas, S. A., X. Li, E. J. Robertson, and M. M. Matzuk. 2006. Premature luteinization and cumulus cell defects in ovarian-specific Smad4 knockout mice. Mol. Endocrinol. 20:1406–1422.
   PubMedGoogle Scholar
• Pangas, S. A., and M. M. Matzuk. 2007. The TGFB family in the reproductive tract. In R. Derynck and K. Miyazono (ed.), The TGFB family. Cold Spring Harbor Press, Cold Spring Harbor, NY.
   Google Scholar
• Pardali, K., and A. Moustakas. 2006. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta 1775:21–62.
   PubMedGoogle Scholar
• Piccirillo, S., B. Reynolds, N. Zanetti, G. Lamorte, E. Binda, G. Broggi, H. Brem, A. Olivi, F. Dimeco, and A. Vescovi. 2006. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain-tumour-initiating cells. Nature 444:761–765.
   PubMed Web of Science ®Google Scholar
• Pouliot, F., and C. Labrie. 2002. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells. J. Endocrinol. 172:187–198.
   PubMed Web of Science ®Google Scholar
• Risma, K., C. Clay, T. Nett, T. Wagner, J. Yun, and J. Nilson. 1995. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc. Natl. Acad. Sci. USA 92:1322–1326.
   PubMed Web of Science ®Google Scholar
• Roberts, A. B., and L. M. Wakefield. 2003. The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. USA 100:8621–8623.
   PubMed Web of Science ®Google Scholar
• Rose, P. G., M. S. Piver, Y. Tsukada, and T. Lau. 1989. Metastatic patterns in histolologic variants of ovarian cancer. Cancer 64:1508–1513.
   PubMed Web of Science ®Google Scholar
• Schneider, D., J. Kleeff, P. O. Berberat, Z. Zhu, M. Korc, H. Friess, and M. W. Buchler. 2002. Induction and expression of betaig-h3 in pancreatic cancer cells. Biochim. Biophys. Acta 1588:1–6.
   PubMedGoogle Scholar
• Sgarra, R., A. Rustighi, M. A. Tessari, J. Di Bernardo, S. Altamura, A. Fusco, G. Manfioletti, and V. Giancotti. 2004. Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett. 574:1–8.
   PubMed Web of Science ®Google Scholar
• Shim, C., W. Zhang, C. H. Rhee, and J. H. Lee. 1998. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin. Cancer Res. 4:3045–3050.
   PubMed Web of Science ®Google Scholar
• Singbrant, S., J. L. Moody, U. Blank, G. Karlsson, L. Umans, A. Zwijsen, and S. Karlsson. 2006. Smad5 is dispensable for adult murine hematopoiesis. Blood 108:3707–3712.
   PubMedGoogle Scholar
• Sneddon, J. B., H. H. Zhen, K. Montgomery, M. van de Rijn, A. D. Tward, R. West, H. Gladstone, H. Y. Chang, G. S. Morganroth, A. E. Oro, and P. O. Brown. 2006. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc. Natl. Acad. Sci. USA 103:14842–14847.
   PubMed Web of Science ®Google Scholar
• Steeg, P. S. 2006. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12:895–904.
   PubMed Web of Science ®Google Scholar
• Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, and J. P. Mesirov. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102:15545–15550.
   PubMed Web of Science ®Google Scholar
• Tremblay, K. D., N. R. Dunn, and E. J. Robertson. 2001. Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 128:3609–3621.
   PubMed Web of Science ®Google Scholar
• Umans, L., L. Vermeire, A. Francis, H. Chang, D. Huylebroeck, and A. Zwijsen. 2003. Generation of a floxed allele of Smad5 for cre-mediated conditional knockout in the mouse. Genesis 37:5–11.
   PubMedGoogle Scholar
• Zaidi, M. R., Y. Okada, and K. K. Chada. 2006. Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice. Cancer Res. 66:7453–7459.
   PubMed Web of Science ®Google Scholar
• Zeisberg, M., J. Hanai, H. Sugimoto, T. Mammoto, D. Charytan, F. Strutz, and R. Kalluri. 2003. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9:964–968.
   PubMed Web of Science ®Google Scholar
• Zhan, Y., A. Fujino, D. T. MacLaughlin, T. F. Manganaro, P. P. Szotek, N. A. Arango, J. Teixeira, and P. K. Donahoe. 2006. Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression. Development 133:2359–2369.
   PubMed Web of Science ®Google Scholar